Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$82.4M Buy
1,090,660
+452,018
+71% +$34M 0.01% 947
2025
Q4
$47.6M Sell
638,642
-2,357,977
-79% -$172M 0.01% 1462
2025
Q3
$202M Sell
2,996,619
-712,328
-19% -$47.3M 0.03% 478
2025
Q2
$242M Buy
3,708,947
+3,451,781
+1,342% +$207M 0.04% 346
2025
Q1
$15.9M Sell
257,166
-128,488
-33% -$8.51M ﹤0.01% 2295
2024
Q4
$27.8M Buy
385,654
+360,901
+1,458% +$28.2M ﹤0.01% 1816
2024
Q3
$2.02M Buy
24,753
+22,373
+940% +$1.79M ﹤0.01% 5517
2024
Q2
$177K Sell
2,380
-1,661,494
-100% -$125M ﹤0.01% 10106
2024
Q1
$130M Sell
1,663,874
-1,373,780
-45% -$102M 0.03% 564
2023
Q4
$217M Sell
3,037,654
-3,215,274
-51% -$224M 0.04% 323
2023
Q3
$434M Buy
6,252,928
+5,016,651
+406% +$379M 0.09% 120
2023
Q2
$100M Buy
1,236,277
+561,576
+83% +$45.9M 0.02% 610
2023
Q1
$54.4M Buy
674,701
+70,854
+12% +$5.7M 0.01% 1005
2022
Q4
$45.2M Buy
603,847
+346,142
+134% +$24.6M 0.01% 1202
2022
Q3
$16.6M Buy
257,705
+253,906
+6,683% +$17.6M ﹤0.01% 2093
2022
Q2
$263K Buy
+3,799
New +$282K ﹤0.01% 10115
2022
Q1
Sell
-813,208
Closed -$58.5M 13997
2021
Q4
$62.3M Buy
+813,208
New +$59.8M 0.01% 999
2021
Q3
Sell
-2,235,990
Closed -$168M 14151
2021
Q2
$149M Buy
2,235,990
+2,217,550
+12,026% +$148M 0.03% 466
2021
Q1
$1.37M Sell
18,440
-637,977
-97% -$48.4M ﹤0.01% 7330
2020
Q4
$47.8M Buy
656,417
+196,925
+43% +$13.9M 0.01% 973
2020
Q3
$30.5M Sell
459,492
-4,666,122
-91% -$295M 0.01% 1206
2020
Q2
$292M Buy
5,125,614
+2,093,680
+69% +$103M 0.1% 98
2020
Q1
$106M Buy
3,031,934
+1,905,473
+169% +$90.7M 0.05% 315
2019
Q4
$58.8M Sell
1,126,461
-456,795
-29% -$22.7M 0.03% 680
2019
Q3
$79.9M Buy
1,583,256
+1,491,537
+1,626% +$73.4M 0.04% 499
2019
Q2
$4.4M Buy
+91,719
New +$4.24M ﹤0.01% 3289
2018
Q4
Sell
-303,457
Closed -$12.4M 9390
2018
Q3
$12.4M Buy
303,457
+283,858
+1,448% +$11.5M 0.01% 1865
2018
Q2
$779K Sell
19,599
-66,450
-77% -$2.56M ﹤0.01% 5636
2018
Q1
$3.21M Buy
86,049
+8,369
+11% +$338K ﹤0.01% 3044
2017
Q4
$3.32M Sell
77,680
-252,123
-76% -$10.1M ﹤0.01% 2977
2017
Q3
$12.1M Buy
329,803
+158,875
+93% +$6.41M 0.01% 1438
2017
Q2
$7.76M Sell
170,928
-381,893
-69% -$16.9M 0.01% 1674
2017
Q1
$23.5M Sell
552,821
-461,811
-46% -$18.8M 0.02% 842
2016
Q4
$40.7M Sell
1,014,632
-1,796,907
-64% -$69.3M 0.04% 467
2016
Q3
$109M Buy
2,811,539
+1,689,428
+151% +$63.8M 0.11% 144
2016
Q2
$38.8M Buy
1,122,111
+163,517
+17% +$5.66M 0.04% 451
2016
Q1
$33.1M Buy
958,594
+793,508
+481% +$27.7M 0.04% 470
2015
Q4
$6.39M Sell
165,086
-325,864
-66% -$12.7M 0.01% 1611
2015
Q3
$19.2M Buy
490,950
+487,308
+13,380% +$19.3M 0.02% 938
2015
Q2
$139K Buy
+3,642
New +$127K ﹤0.01% 6730
2015
Q1
Sell
-31,551
Closed -$968K 8655
2014
Q4
$844K Sell
31,551
-93,309
-75% -$2.41M ﹤0.01% 3980
2014
Q3
$3.04M Sell
124,860
-1,657
-1% -$41.8K ﹤0.01% 2451
2014
Q2
$3.21M Buy
126,517
+69,236
+121% +$1.62M ﹤0.01% 2257
2014
Q1
$1.23M Sell
57,281
-289,088
-83% -$6.24M ﹤0.01% 3176
2013
Q4
$7.74M Sell
346,369
-595,722
-63% -$13.1M 0.01% 1385
2013
Q3
$19.5M Buy
942,091
+787,016
+508% +$16.8M 0.03% 728
2013
Q2
$2.99M Buy
+155,075
New +$3.24M 0.01% 2062

Other funds holding HOLX

Ken Griffin's HOLX Position: Q1 2026 in Review

Ken Griffin increased its Hologic (HOLX) stake by 71% in Q1 2026, buying an estimated $34M and bringing the position to 1,090,660 shares worth $82.4M. The position accounts for 0.01% of the portfolio, ranked #947.

Ken Griffin first reported a position in HOLX in Q2 2013 and has held it in 47 quarters since. The position peaked at $434M in Q3 2023. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Ken Griffin held 1,090,660 shares of Hologic worth $82.4M as of Q1 2026.
  • Ken Griffin bought 452,018 Hologic shares in Q1 2026, an estimated $34M.
  • Hologic made up 0.01% of Ken Griffin's portfolio in Q1 2026, its #947 holding.
  • Ken Griffin first reported a position in Hologic in Q2 2013 and has held it in 47 quarters since.
  • Ken Griffin's Hologic position peaked at $434M in Q3 2023.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.